How often should the insulin injections pen needle be changed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Insulin Pen Needle Replacement Frequency

Insulin pen needles should be changed after every single injection—they are designed for one-time use only and must never be reused. 1

Official Guideline Recommendations

The most recent 2025 Mayo Clinic guidelines explicitly state that patients should avoid reusing needles because they are no longer sterile after being used and may become blunted or misshapen over time, which increases injection force, pain, and contributes to elevated risk of lipohypertrophy development. 1

  • Remove the pen needle immediately after each injection to prevent air seepage into the cartridge, which could impact dosing accuracy and lead to serious underdosing. 1, 2, 3
  • Manufacturers of disposable pen needles recommend they only be used once, and official labeling requires both single-use and sterility symbols. 4, 5
  • The FDA-approved insulin glargine label explicitly instructs: "Do not reuse needles" and emphasizes using "a new sterile needle for each injection" to help stop blocked needles, contamination, and infection. 2

Clinical Consequences of Needle Reuse

While needle reuse is extremely common globally (40-96% of patients reuse needles), there are documented associations with adverse outcomes: 1

  • Lipohypertrophy risk: There is a significant association between needle reuse and development of lipohypertrophy (lumpy, thickened skin at injection sites), with pooled data showing a 16% increased absolute risk. 5, 6
  • Increased pain and bleeding: Reused needles become dull and deformed, even after a single use, which increases injection pain and bleeding risk. 4, 5
  • Needle deformation: Even with one injection, newer smaller gauge needles (30-31 gauge) can become bent to form a hook which can lacerate tissue or break off, leaving needle fragments within the skin. 4
  • Dosing inaccuracy: Air accumulation in cartridges when needles are left attached between injections can result in serious underdosing—with 200 microliters of air, patients receive only 37% of their intended dose. 3

The Reality of Needle Reuse in Practice

Despite clear recommendations against reuse, the 2025 guidelines acknowledge practical limitations: 1

  • Insufficient evidence exists on the maximum allowable number of injections with one needle, though one study suggested pen needles could be used 4-5 times without increasing pain intensity. 1
  • If a patient does not have a new needle available, reusing one of their own needles may be preferable to missing an injection entirely. 1
  • The 2016 guidelines note that patients who reuse needles should not be subjected to alarming claims of excessive morbidity, as infection risk appears minimal due to bacteriostatic additives in insulin formulations. 5, 7
  • A 1992 study of 20 patients performing over 33,000 injections with needle reuse showed no signs of local infection, with only one needle showing bacterial colonization. 8

Key Safety Practices When Changing Needles

Always dispose of used needles in a puncture-resistant sharps container and never recap needles, as this increases needlestick injury risk to both patients and healthcare workers. 4, 9, 10

  • Use the shortest available needles (4-mm pen needles) to minimize pain and reduce intramuscular injection risk. 5, 1
  • Inspect injection sites regularly for signs of lipohypertrophy (lumps, thickened areas) and avoid injecting into these areas. 5, 1
  • Store pens without needles attached between injections to prevent air accumulation and contamination. 1, 2

Bottom Line

The standard of care is single-use only—one injection per needle, then immediate disposal. While the evidence on infection risk from reuse is limited, the documented associations with lipohypertrophy, increased pain, needle deformation, and dosing inaccuracy provide compelling reasons to follow manufacturer recommendations and use a fresh needle for every injection. 1, 5

References

Research

The kinetics of insulin administration by insulin pens.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1994

Guideline

insulin administration.

Diabetes Care, 2004

Guideline

new insulin delivery recommendations.

Mayo Clinic Proceedings, 2016

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Guideline

Insulin Syringe Needle Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

For a 19‑year‑old with type 1 diabetes, weight 86 kg, creatinine 0.74 mg/dL, GFR > 90 mL/min, bicarbonate 17 mmol/L, anion gap 13, currently on metformin 750 mg daily and insulin glargine (Lantus) 15 U at 8 am and 35 U at 8 pm with carbohydrate‑to‑insulin ratios of 1 U per 6 g carbs at breakfast and 1 U per 7 g carbs at lunch/dinner and an insulin‑sensitivity factor of 25 mg/dL per U, and blood glucose values of 184 mg/dL (8 am), 220 mg/dL (noon), 262 mg/dL (5 pm), 237 mg/dL (10 pm), and 97 mg/dL (4 am), what should the morning and evening Lantus doses be and what should the insulin‑sensitivity factor and insulin‑to‑carbohydrate ratios be adjusted to?
What does a basal insulin level of 2.3 (microunits per milliliter) indicate in a 48-year-old man with no known diabetes?
In a 27‑year‑old woman with type 2 diabetes, weight 86.6 kg, creatinine 0.40 mg/dL, GFR > 90 mL/min, currently taking neutral protamine Hagedorn (NPH) insulin 32 U at 8 am, dexamethasone 20 mg daily, with an insulin‑to‑carbohydrate ratio (ICR) of 1 U per 3 g carbohydrate and an insulin sensitivity factor (ISF) of 25 mg/dL per U, and blood glucose values of 207 mg/dL at 9 am, 229 mg/dL after a 90‑g carbohydrate meal, 373 mg/dL at 5 pm, 340 mg/dL at 9 pm, and 286 mg/dL at 2 am, what should the NPH basal insulin dose, ISF, and ICR be adjusted to?
A 28‑week‑gestation pregnant woman weighing 114 kg has a fasting blood glucose of 157 mg/dL while on insulin glargine (Lantus) 40 units daily; how much should the insulin glargine dose be increased?
How should a 19‑year‑old female with a family history of diabetes, normal fasting glucose (88 mg/dL) and HbA1c (5.2 %), but elevated fasting insulin (47.3 µU/mL) be managed?
Why is diphenhydramine (Benadryl) not recommended for children?
What is the typical age range for Primary Biliary Cholangitis (PBC) diagnosis?
What is the presentation of sinusitis associated with Coccidioidomycosis?
What is the average monthly cost of Vyvanse (Lisdexamfetamine) 20 mg a day in Canada?
What ICD-10 code to use for a patient started on Depakote (valproate) for mood stabilization?
What treatment should be given to a patient with allergic contact dermatitis secondary to hair dye exposure, presenting with facial edema, neck swelling, and soft palate swelling, currently taking cetirizine (Cetirizine) 10 mg and montelukast (Montelukast) 10 mg?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.